Scientists at Sanford Burnham Prebys have identified the long-sought structure of an essential blood protein: Vitronectin
On Sept. 11, 2019, scientists at Sanford Burnham Prebys announced they had identified the long-sought structure of an…
IRBM signed agreement with MD Anderson Cancer Center to generate novel immune-checkpoint monoclonal antibodies
On Sept. 9, 2019, IRBM announced the signing of a service and development agreement with The University of…
MouseLight Project mapped 1,000 neurons in the mouse brain
On Sept. 5, 2019, researchers at the Howard Hughes Medical Instituteï¾’s Janelia Research Campus announced that they had…
Penn researcher Virginia MY Lee, PhD, received $3 million Breakthrough Prize
On Sept. 5, 2019, Penn Professor Virginia M.Y. Lee, PhD received the Breakthrough Prize in Life Sciences, in…
University of Alberta researchers discovered the protein PEX3 in the cells of deadly parasite trypanosome
On Aug. 26, 2019, University of Alberta researcher Rick Rachubinski and colleagues announced they had discovered the protein…
Amgen acquired worldwide rights to psoriasis drug Otezla (apremilast) For $13.4 Billion
On Aug. 26, 2019, Amgen acquired worldwide rights to Otezlaï¾® (apremilast), the only oral, non-biologic treatment for psoriasis…
The City of Port St Lucie Council voted to ï¾ Leaseï¾ the former VGTI Florida facility to the ï¾ Cleveland Clinic for $1 per year for 15 years
On Aug. 26, 2019 , the City of Port St. Lucie Council voted 5 to 0 to ï¾ leaseï¾ …
Siteman Cancer Center received $15 million grant to support personalized leukemia therapies
On Aug. 21, 2019, the Siteman Cancer Center announced it was awarded a $15 million grant to better…
Masonic Cancer Center researchers awarded $8.5 million dollar grant to research metastatic breast cancer
On Aug. 15, 2019, Masonic Cancer Center researchers Reuben Harris, PhD and Douglas Yee, MD announced that they…
Siteman Cancer Center awarded $78 million to expand clinical trials access
On Aug. 1, 2019 the Siteman Cancer Center announced it was awarded a six-year, $7.8 million grant from…
Vanderbilt University Medical Center Professor David Cortez, PhD and colleagues revealed a new DNA repair pathway
On Jul. 25, 2019, Vanderbilt University Medical Center Professor David Cortez, PhD and colleagues revealed a new DNA…
CDC published ACIP recommendations on use of Japanese encephalitis vaccine
On Jul. 19, 2019, the Centers for Disease Control and Prevention (CDC) published recommendations from the Advisory Committee…
Masonic Cancer Center member Ingunn Stromnes, PhD awarded with PanCAN Grant
On Jul. 9, 2019, the Masonic Cancer Center announced that researcher Ingunn Stromnes, PhD was awarded with a…
Evotec completed acquisition of Just Biotherapeutics
On Jul. 3, 2019, Evotec announced the strategic transaction to acquire Just Biotherapeutics, signed May 20, 2019, had…
DARPA funded a $21.9 gene modulation research initiative at Georgia Tech, targeting influenza pandemics
In Jun. 2019, Defense Advanced Research Projects Agency (DARPA) announced it had funded a $21.9 gene modulation research…
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 signed into law
On Jun. 24, 2019, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (S.1379) passed by…
CanSinoBIO received approval for Its 13-valent penumococcal conjugate vaccine to start clinical trials
On Jun. 20, 2019, CanSino Biologics announced that it had received the National Medical Products Administration’s (NMPA) permission…
Biotechnology | CRISPR | Diagnostics | Genomics | Life Science News | Non-Profit Research | Therapeutics
New CRISPR Lab for Genomic Research at UCSF and UC Berkeley in collaboratation with GlaxoSmithKline
On Jun. 13, 2019, the University of California, San Francisco and University of California, Berkeley collaborated with GlaxoSmithKline…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Non-Profit Research | Therapeutics
Groundbreaking DNA study launched to discover new connections between genetics & diseases
On Jun. 12, 2019, Intermountain Healthcare and deCODE genetics announced a major global collaboration and study focused on…
Vaccitech universal flu vaccine passed Phase 2b clinical development milestones
On Jun. 5, 2019, Vaccitech announced that it has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100)…
The Cancer Prevention and Research Institute of Texas awarded a relocation grant to Hummingbird Bioscience
On Jun. 4, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded a $13 million relocation…
Penn received a $12 million grant to study the connection between cellular therapies and new methods of radiation therapy
On Jun. 3, 2019, the University of Pennsylvania (Penn) announced it had received a $12 million grant from…
The Richard N Merkin Institute for Translational Research was founded at CalTech
On May 30, 2019, The Richard N. Merkin Institute for Translational Research was founded at CalTech. Merkin, who…
Masonic Cancer Center researchers discovered importance of protein p300 acetyltransferase in liver cancer development
On May 3, 2019, Masonic Cancer Center researcher Dr. Ningling Kang and colleauges at The Hormel Institute announced…
Massachusetts General Hospital received $200 million to advance research into complex diseases
On Apr. 26, 2019, Massachusetts General Hospital (MGH) announced it had received the largest gift in the hospital’s…
UGA researchers discovered a vaccine for Crimean-Congo Hemorrhagic Fever (CCHF) virus
On Apr. 25, 2019, researchers at the University of Georgia announced they had successfully discovered a single-dose vaccine…
Amgen announced FDA approval of EVENITY for the treatment of osteoporosis
On Apr. 9 2019, Amgen announced U.S. Food and Drug Administration (FDA) approval of EVENITY (romosozumab-aqqg) for the…
Chembio Diagnostics received approval of Zika, Dengue and Chikungunya point-of-care multiplex test by Brazil’s Health Regulatory Agency
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
The only FDA approved IV antimalarial in the US, IV quinidine, was discontinued
In Mar. 29, 2019, the Centers for Disease Control and Prevention (CDC) issued new guidance to clinicians for…
Masonic Cancer Center researcher Dr. Liang Liu received skin cancer research grant
On Mar. 13, 2019, Dr. Liang Lie of Mason Cancer Center’s Hormel Institute received a skin cancer research…